Fibrinogen receptor antagonists
- 1 May 1994
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 3 (5) , 437-448
- https://doi.org/10.1517/13543784.3.5.437
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibodyThe American Journal of Cardiology, 1993
- Inhibition of coronary artery reocclusion after thrombolysis with an RGD-containing peptide with no significant effect on bleeding timeCoronary Artery Disease, 1993
- Pharmacological Blockade of Platelet GPIIb/llla and the Inherited Disorders of the Platelet GPIIb/llla (Glanzmann’s Thrombasthenia): How Safe Is This Antithrombotic Approach for Both Acute and Chronic Treatment of Thromboembolic Disorders?Cardiology, 1993
- Low molecular weight, non-peptide fibrinogen receptor antagonistsJournal of Medicinal Chemistry, 1992
- Cyclic RGD peptide analogs as antiplatelet antithromboticsJournal of Medicinal Chemistry, 1992
- Ligands “activate” integrin αIIbβ3 (platelet GPIIb-IIIa)Cell, 1991
- The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.Journal of Clinical Investigation, 1991
- T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1Nature, 1989
- Localization of an Arg-Gly-Asp Recognition Site Within an Integrin Adhesion ReceptorScience, 1988
- Platelet-collagen adhesion: inhibition by a monoclonal antibody that binds glycoprotein IIb.The Journal of cell biology, 1984